Group B streptococci (GBS) are a significant cause of invasive bacterial disease in human neonates, parturient women, and patients with underlying illnesses. Bacterial virulence factors that contribute to the pathogenesis of GBS disease have not been completely defined. The purpose of the proposed research is to identify and characterize virulence factors contributing to disease caused by two of the most common GBS serotypes, type I and III, that produce disease in humans. One putative GBS virulence factor is C5a-ase, an enzyme that rapidly inactivates the potent polymorphonuclear (PMN) chemoattractant C5a. This enzyme could contribute to the virulence of GBS by reducing PMN accumulation at the site of bacterial invasion, thereby permitting bacterial multiplication and systemic invasion.
The first aim of this proposal is to determine if antibodies to C5a-ase can neutralize the C5a-ase activity on type I GBS or initiated opsonization of GBS in the presence of complement, and to determine the contribution of C5a-ase to the virulence of type I GBS. Work presented in this proposal indicates that the majority of invasive type III GBS infections are caused by a group of closely related organisms, called RDP III-3, based on the similarity of the restriction digest patterns (RDPs) of bacterial DNA following enzymatic digestion with Hind III and Sse 83871. Unique DNA sequences that are present only in III-3 strains have been identified by subtractive hybridization of genomic DNA from III-3 and III-2 strains. In the work proposed in Aim 2, the III-3 genes in which these sequences are contained will be characterized (cloned and sequenced). The resulting data will delineate the genetic differences between the virulent and avirulent RDP types, and disclose the mechanisms by which GBS become genetically divergent and become virulent. Genes that are unique to III-3 strains are likely to encode virulence factors that increase the pathogenicity of the III-3 strains. In the third and final aim, candidate virulence genes will be inactivated in the virulent III-3 strains, and avirulent III-2 strains will be transformed with these virulence genes, in order to determine their role in disease pathogenesis. This approach will ultimately contribute to understanding the molecular basis of disease caused by GBS, and help devise strategies for preventing and treating this important cause of serious human neonatal bacterial infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI040918-01A2
Application #
2700008
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1998-07-01
Project End
2002-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Utah
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Chattopadhyay, Debasish; Carey, Alison J; Caliot, Elise et al. (2011) Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus. Microbes Infect 13:369-382
Seifert, Kyle N; Adderson, Elisabeth E; Whiting, April A et al. (2006) A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 152:1029-40
Ulett, Glen C; Maclean, Kirsteen H; Nekkalapu, Sunitha et al. (2005) Mechanisms of group B streptococcal-induced apoptosis of murine macrophages. J Immunol 175:2555-62
Ulett, Glen C; Adderson, Elisabeth E (2005) Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis. J Infect Dis 191:1761-70
Bohnsack, John F; Whiting, April A; Martinez, Gabriela et al. (2004) Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis 10:1412-9
Fleming, Katherine E; Bohnsack, John F; Palacios, Geraldo C et al. (2004) Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS). J Med Microbiol 53:505-8
Harris, Theresa O; Shelver, Daniel W; Bohnsack, John F et al. (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111:61-70
Adderson, Elisabeth E; Takahashi, Shinji; Wang, Yan et al. (2003) Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun 71:6857-63
Bohnsack, John F; Whiting, April A; Bradford, Russell D et al. (2002) Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun 70:134-9
Takahashi, Shinji; Detrick, Shauna; Whiting, April A et al. (2002) Correlation of phylogenetic lineages of group B Streptococci, identified by analysis of restriction-digestion patterns of genomic DNA, with infB alleles and mobile genetic elements. J Infect Dis 186:1034-8

Showing the most recent 10 out of 13 publications